8/29/2022

speaker
Operator
Conference Call Moderator

Hello and welcome to Riv Capital's first quarter 2023 earnings conference call. I am joined this morning by Mark Sims, Chief Executive Officer, Matt Mundy, Chief Strategy Officer and General Counsel, and Eddie Luccarelli, Chief Financial Officer. For your convenience, the press release, MD&A and condensed interim consolidated financial statements for the three months ended June 30, 2022 are available on the investor section of the company's website at www.rivcapital.com as well as on CDAR. Before we start, please note that remarks on this conference call may contain forward-looking information within the meaning of applicable securities laws about Riv Capital, its investees and attain, current and future plans, expectations, intentions, financial results, levels of activity, performance, goals or achievements, or any other future events, trends, or developments. To the extent any forward-looking information contained in the remarks constitutes financial outlook, this information may not be appropriate for any other purpose and you should not place undue reliance on such financial outlook. Forward-looking statements are made as of the date hereof based on information currently available to management and on estimates and assumptions based on factors that management believes are appropriate and reasonable in these circumstances. However, there can be no assurance that some estimates and assumptions will prove to be correct. Many factors could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Financial outlooks are also based on assumptions and subject to various risks, and the company's actual financial position and results of operation may differ materially from management's current expectations. As a result, Riv Capital cannot guarantee that any forward-looking statements will materialize and you are cautioned not to place undue reliance on those forward-looking statements. Forward-looking information is made as of the date given and except as may be required by law. Riv Capital undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. For additional information on these assumptions and risks, please consult the cautionary statement regarding forward-looking information contained in the company's financial results. Press release dated August 30, 2022, and the risk factors referenced in the Q1 2023 NDNA and RIV Capital's Annual Information Form. In addition, this call may contain certain market and industry data obtained from various publicly available sources. Although the company believes that these independent sources are generally reliable, the accuracy and completeness of such information is not guaranteed and has not been verified due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process, and the limitations and uncertainty inherent in any statistical survey of market size, conditions and prospects. The company does not make any representation as to the accuracy of such information. As described in further detail in the Q1 2023 financial statements and related MD&A, in light of the Attain acquisition, the company changed the presentation currency of its consolidated financial statements from the Canadian dollar to the US dollar effective April 1, 2022. All dollar amounts expressed today, unless otherwise stated, are in Canadian currency. I would now like to turn the conference over to your host, Mr. Mark Sims, President and Chief Executive Officer of Riv Capital. Thank you. You may begin.

speaker
Mark Sims
President and Chief Executive Officer

Thank you, Operator, and welcome everyone to our first quarter 2023 earnings call. I will begin today's call by providing an update on our acquisition of New York-based Attain and outlining our U.S. strategy before turning it over to Chief Strategy Officer and General Counsel Matt Mundy for a brief regulatory outlook on New York, followed by a review of our financial results with our CFO, Eddie Luccarelli. We began Q1 by taking the first step in our previously announced strategic shift into the U.S. cannabis market with our proposed acquisition of New York-based Attain. which includes Attain's New York registered organization license, allowing for cultivation, processing, and retail medical dispensaries, four of which are currently active. We are pleased to complete the initial closing in April of Attain's unregulated assets and look forward to completing the second and final phase during the second half of this year. Following the initial close, we remain confident that we have selected the ideal platform for growth as the New York market approaches the launch of adult use sales. While the final transfer of Attain LLC's equity interests, which is the entity holding the RO license in New York, is currently under review by New York state regulators, the structure of the acquisition gives us ownership of Attain's non-regulated assets before the final equity transfer of the license holding entity occurs. As such, we have been diligently working with the ATTAIN team to appropriately scale their existing infrastructure, processes, and systems in support of the public reporting requirements of their capital and a steady ramp to adult use sales. We believe that we have a significant advantage in our ability to expand the existing Etain business into a larger platform designed for long-term, sustained growth. Part of our strategy to strengthen our bench included the appointment of Mike Totski as Chief Operating Officer in June. Mr. Totski's extensive operational experience from the Hawthorne Collective and Scott's Miracle-Gro will prove critical to the launch of our New York operations. And his deep operational and sales backgrounds further positions us for the successful execution of our U.S. strategy. His primary goal will be to drive sales, optimize operations, and expand Attain's existing infrastructure in preparation for serving New York's medical and forthcoming adult use markets. Despite the ongoing challenges in the existing medical market, which Matt will get into further detail in a minute, Etain has carved out a premium niche that we believe will serve as the foundation for our platform to grow market share. In the near term, we plan to complete the expansion of Etain's hybrid greenhouse in Chestertown, extending its current cultivation capacity and enabling us to develop new product formats in advance of the launch of adult use sales. We will also be upgrading Attain's existing retail locations to prepare for the expected increase in customer traffic and sales volume. On top of that, we are currently evaluating locations for the four new dispensaries permitted under the Attain license, which would ultimately bring Attain's total New York footprint to eight retail locations, three of which will be co-located for adult use once legally permitted. are pleased to report that we are now in the process of constructing our new state-of-the-art flagship indoor cultivation facility in buffalo the new facility is designed with premier cultivation and production infrastructure specifically tailored to support the premium new york market importantly A 7,000 square foot portion of the new facility will be designated specifically to host social equity licensees. We believe this step will further strengthen the broader New York market by supporting the state's initiatives for an equitable cannabis industry, all while securing new wholesale opportunities and other potential partnerships for Riv Capital. We have executed a lease for the build-out and occupation of the Buffalo property, which includes conditions requiring necessary regulatory approvals, such as from New York's Office of Cannabis Management. We expect a significant ramp in our business to occur once adult use sales have taken effect, with our expanded operations coming online to satisfy the growing consumer demand that is expected across the state. Our long-term strategy is to build a leading multi-state operating and brand platform, with New York serving as our foundation. We plan to develop and expand new brands and products designed to resonate with New York consumers, offered alongside Etain's popular product line as one of our core brands, which will include new form factors such as pre-rolls and other SKUs later this year. While we are, of course, laser focused on getting New York right before undertaking any significant expansions elsewhere, We are always evaluating new attractive opportunities that can accelerate our brand platform strategy, and we continue to actively explore M&A opportunities as part of our overall corporate strategy. During these dynamic, incredibly active times for the industry, our strong liquidity enables us to build our U.S. platform as the broader market evolves. What's possible today may not be tomorrow, and we intend to take full advantage of our significant cash position when the right opportunity presents itself. We look forward to providing updates on our strategy and progress as our U.S. operations begin to scale. We believe that we have a significant advantage in our ability to expand the existing Etain business in New York into a larger platform designed for long-term sustained growth. We are excited to enter the U.S. market as an operator in partnership with the outstanding Etain team and brand, and we eagerly await the final completion of the Etain acquisition. With that, I will now turn the call over to Matt Mundy, Chief Strategy Officer and General Counsel, for a regulatory outlook on the New York market.

speaker
Matt Mundy
Chief Strategy Officer and General Counsel

Matt? Thanks, Mark. As Mark just mentioned, despite significant noise around the New York market over the past several months, we strongly believe that the Etain asset we have purchased is an ideal platform for growth. As we mentioned before, we believe that New York will be the country's most exciting legal cannabis market over the next several years, with the potential to follow only California in sales. New York is forecasted to generate around $1.5 billion in sales in the first 12 months of adult use legalization, and roughly $3 billion of annual sales by 2026. We chose to begin the implementation of our strategic entry into the US market in New York for several reasons. First, we believe that the state's imminent launch of adult use sales will be transformative for the industry as a whole. This will be a truly landmark moment for the industry. And we think that playing a meaningful role in that moment will create substantial value for our shareholders now and into the future. Second, we think that timing our entrance into New York just as adult use is going to come online will do much to capitalize on the rapid growth potential in the New York market in the next couple of years. Third, we believe that New York offers us the best platform to launch our brand-focused strategy, and that the outsized cultural influence of New York City is going to allow brands that succeed there to reap disproportionately large rewards as the industry continues to unroll nationwide in the years ahead. While we work with Attain to achieve final regulatory approval and closing of the Attain transactions, our strategy continues to be informed by the existing medical market, which is struggling to operate effectively. Medical card renewal programs have encountered setbacks, and patient head counts continue to drop, all while the unlicensed gray market grows ever more prominent and lucrative. Despite this, we believe recent momentum in New York on the regulatory side is cause for optimism, and we remain bullish on the future regulatory landscape as the rollout of adult use continues over the coming months. Furthermore, understanding the market's current challenges will enable us to better address the potential challenges in the early days of adult use sales. We also believe we have the wherewithal to improve the existing medical cannabis market by prioritizing patient access and participation. and feel we are well positioned to translate those improvements into a stronger footing for widespread adult use. We are vocal supporters of the state's focus on social equity and look forward to working alongside social equity applicants and participants to grow the local market together. We believe that the Social Equity Retail License Program in New York presents an attractive opportunity for our future wholesale business and aligns well with our growth strategy. As Mark mentioned, we are leaning into the state's initiatives by designating a considerable section of our flagship facility for social equity operators. We believe that this approach will incubate new business opportunities for both RIV and the local community, while strengthening and diversifying the market in an equitable manner. We are incredibly excited about the opportunity in front of us, and we believe that we are uniquely positioned to create a market-leading, consumer-focused platform in what we believe will be the world's most exciting cannabis market in the coming years. I'll now hand the line to Eddie, who will walk us through our financial results. Eddie?

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-